Companies: 10,795·Total market cap: $144.5T

CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTCNASDAQHealthcare● Active

$1.15

$-0.14(-10.85%)

Market Cap$13607760

P/E Ratio—

52W High$3.68

52W Low$0.68

Avg Volume14K

Open$1.14

Beta-0.04

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

CytoMed Therapeutics Limited（GDTC）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · GDTC · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.46Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)509129.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding11.6MShares outstanding history

Next EarningsNov 13, 2026Est.Earnings history

探索 CytoMed Therapeutics Limited 数据

分析师预测$— · Buy

股息不分红

营收$319201+359.28%

盈利EPS $-0.33-50.00%

财务快照

FY 2025Revenue$319201.00▲ +359.28% YoY

202320242025

FY 2025Net Income-$3.9M▼ 52.33% YoY

202320242025

FY 2025EPS$-0.33▼ 50.00% YoY

202320242025

TTM:Revenue: $509129.00Net Income: -$5.5MEPS: $-0.46View income statement →

分析师评级与目标价

Buy1 位分析师

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$1.15Current

$—Avg Target

$—High

合计: 1 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

CytoMed Therapeutics Limited

$1.15-10.85%$13.6M #2

CollPlant Biotechnologies Ltd.

$0.37-0.27%$4.5M #3

Enlivex Therapeutics Ltd.

$0.71+0.59%$17.4M #4

Lisata Therapeutics, Inc.

$3.48+3.88%$31.7M #5

$2.22-13.62%$4.9M #6

$2.05+5.13%$12.4M

股票表现

1D-10.85%

1W+2.68%

1M+47.44%

3M+9.52%

YTD-14.18%

1Y-44.98%

5Y-71.25%

关于 CytoMed Therapeutics Limited

CEOChee Kong Choo

IPO DateApr 14, 2023

Employees43

CountrySG

Websitew2.cytomed.sg

CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunother…

Biotechnology HealthcareNASDAQSG

关于股票概览与关键数据

CytoMed Therapeutics Limited（GDTC）是 Biotechnology 行业的 Healthcare 类公司，于 Apr 14, 2023 在 NASDAQ 上市。截至最近交易日，GDTC 股价为 $1.15，市值约为 $13.6M。过去12个月累计回报 -44.98%，年初至今回报 -14.18%。

根据 1 位华尔街分析师，CytoMed Therapeutics Limited 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 CytoMed Therapeutics Limited 营收 $319201.00，净利润 -$3.9M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，CytoMed Therapeutics Limited（GDTC）股价为 $1.15，在 NASDAQ 上市，52周区间为 $0.68 – $3.68。

GDTC 最新股价GDTC quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议